Literature DB >> 20729796

Seroprevalence and determinants of eight high-risk human papillomavirus types in homosexual men, heterosexual men, and women: a population-based study in Amsterdam.

Marlies Heiligenberg1, Kristina M Michael, Merlijn A Kramer, Michael Pawlita, Maria Prins, Roel A Coutinho, Nicole H T M Dukers-Muijrers, Tim Waterboer.   

Abstract

BACKGROUND: To determine differences in the seroprevalence of high-risk human papillomavirus (hrHPV) types between men having sex with men (MSM), heterosexual men and women, we analyzed seroprevalence and risk factors for 8 hrHPV in the general population of Amsterdam, the Netherlands.
METHODS: We interviewed 1349 inhabitants aged ≥17 years and tested sera for antibodies against L1 capsid proteins of 8 hrHPV using Luminex-based multiplex serology. Risk factors for hrHPV were determined by multivariate Poisson analysis.
RESULTS: Seroprevalences for 8 hrHPV ranged from 13.1% for HPV-45 to 31.4% for HPV-35. Seropositivity for HPV-16 and HPV-18 was more common in women and MSM than in heterosexual men. HPV-16 and -18 were more common in subjects also having antibodies against other hrHPV types (prevalence rate ratio [PRR], 2.12, 95% confidence interval [CI] 1.52-2.97; and PRR, 2.00; 95% CI, 1.43-2.81, respectively) and/or herpes simplex virus type 2 (PRR, 1.69; 95% CI, 1.32-2.16; and PRR, 1.47; 95% CI, 1.13-1.92, respectively). HPV-18 was more common in persons with a history of sexually transmitted infections (STI) (PRR, 1.64; 95% CI, 1.20-2.25). HPV-35, -45, and -58 were more common in non-European ethnic groups.
CONCLUSIONS: Prevalence of 8 hrHPV antibodies was high in the Amsterdam population, especially in MSM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20729796     DOI: 10.1097/OLQ.0b013e3181e71069

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  15 in total

Review 1.  Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine: for the prevention of genital warts in males.

Authors:  Karly P Garnock-Jones; Anna R Giuliano
Journal:  Drugs       Date:  2011-03-26       Impact factor: 9.546

2.  Oral human papillomavirus infection in men might contribute to HPV serology.

Authors:  S Syrjänen; T Waterboer; K Kero; J Rautava; K Syrjänen; S Grenman; M Pawlita
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-08-14       Impact factor: 3.267

Review 3.  EUROGIN 2014 roadmap: differences in human papillomavirus infection natural history, transmission and human papillomavirus-related cancer incidence by gender and anatomic site of infection.

Authors:  Anna R Giuliano; Alan G Nyitray; Aimée R Kreimer; Christine M Pierce Campbell; Marc T Goodman; Staci L Sudenga; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2014-07-26       Impact factor: 7.396

4.  Sex differences in HPV immunity among adults without cancer.

Authors:  Melina J Windon; Tim Waterboer; Alexander T Hillel; Wade Chien; Simon Best; Charles Stewart; Lee Akst; Tanya Troy; Noemi Bender; Brett Miles; William R Ryan; Rajarsi Mandal; Karen Pitman; David W Eisele; Carole Fakhry; Gypsyamber D'Souza
Journal:  Hum Vaccin Immunother       Date:  2019-03-19       Impact factor: 3.452

5.  No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.

Authors:  Jonas Blomberg; Fredrik Blomberg; Anna Sjösten; Ali Sheikholvaezin; Agnes Bölin-Wiener; Amal Elfaitouri; Sanna Hessel; Carl-Gerhard Gottfries; Olof Zachrisson; Christina Ohrmalm; Magnus Jobs; Rüdiger Pipkorn
Journal:  Clin Vaccine Immunol       Date:  2012-07-11

6.  Natural immune responses against eight oncogenic human papillomaviruses in the ASCUS-LSIL Triage Study.

Authors:  Lauren E Wilson; Michael Pawlita; Phillip E Castle; Tim Waterboer; Vikrant Sahasrabuddhe; Patti E Gravitt; Mark Schiffman; Nicolas Wentzensen
Journal:  Int J Cancer       Date:  2013-05-29       Impact factor: 7.396

7.  Quadrivalent human papillomavirus (HPV) types 6, 11, 16, 18 vaccine for the prevention of genital warts in males: profile report. demail@springer.com.

Authors:  Karly P Garnock-Jones; Anna R Giuliano
Journal:  Drugs R D       Date:  2012-12-01

8.  Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.

Authors:  Mirte Scherpenisse; Madelief Mollers; Rutger M Schepp; Hein J Boot; Chris J L M Meijer; Guy A M Berbers; Fiona R M van der Klis; Hester E de Melker
Journal:  PLoS One       Date:  2012-11-12       Impact factor: 3.240

9.  Human papillomavirus infection: knowledge, attitudes, and behaviors among lesbian, gay men, and bisexual in Italy.

Authors:  Concetta P Pelullo; Gabriella Di Giuseppe; Italo F Angelillo
Journal:  PLoS One       Date:  2012-08-08       Impact factor: 3.240

10.  HPV16 and HPV18 seropositivity and DNA detection among men who have sex with men: a cross-sectional study conducted in a sexual health clinic in London.

Authors:  Eleanor M King; David Mesher; Pam Sonnenberg; Ezra Linley; Kavita Panwar; Simon Beddows; Kate Soldan; Ray Borrow; Mark Jit; Richard Gilson
Journal:  Sex Transm Infect       Date:  2020-12-23       Impact factor: 3.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.